Ohio Public Employees Retirement System (OPERS)
CDTX

Ohio Public Employees Retirement System (OPERS)’s Cidara Therapeutics CDTX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,800
Closed -$1.94M – 2321
2025
Q4 		$1.94M Buy
+8,800
New +$1.42M 0.01% 1111
2021
Q2 		– Sell
-1,219
Closed -$65K – 1991
2021
Q1 		$65K Buy
1,219
+886
+266% +$43.7K ﹤0.01% 1808
2020
Q4 		$13K Buy
+333
New +$16.6K ﹤0.01% 1928
2020
Q1 		– Sell
-513
Closed -$39K – 1889
2019
Q4 		$39K Buy
+513
New +$23.5K ﹤0.01% 1806

Ohio Public Employees Retirement System (OPERS)'s CDTX Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 8,800 shares — an estimated $1.94M sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in CDTX in Q4 2019 and held it in 4 quarters. The position peaked at $1.94M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 8,800 Cidara Therapeutics shares in Q1 2026, an estimated $1.94M.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Cidara Therapeutics in Q4 2019 and held it in 4 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Cidara Therapeutics position peaked at $1.94M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.